Organon & Co.
OGN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,403 | $6,263 | $6,174 | $6,304 |
| % Growth | 2.2% | 1.4% | -2.1% | – |
| Cost of Goods Sold | $2,688 | $2,515 | $2,294 | $2,382 |
| Gross Profit | $3,715 | $3,748 | $3,880 | $3,922 |
| % Margin | 58% | 59.8% | 62.8% | 62.2% |
| R&D Expenses | $469 | $528 | $471 | $443 |
| G&A Expenses | $1,552 | $1,682 | $1,449 | $1,432 |
| SG&A Expenses | $1,760 | $1,893 | $1,704 | $1,668 |
| Sales & Mktg Exp. | $206 | $209 | $255 | $236 |
| Other Operating Expenses | $0 | $0 | $0 | -$104 |
| Operating Expenses | $2,229 | $2,421 | $2,175 | $2,007 |
| Operating Income | $1,486 | $1,327 | $1,705 | $1,915 |
| % Margin | 23.2% | 21.2% | 27.6% | 30.4% |
| Other Income/Exp. Net | -$679 | -$654 | -$583 | -$386 |
| Pre-Tax Income | $807 | $673 | $1,122 | $1,529 |
| Tax Expense | -$57 | -$350 | $205 | $178 |
| Net Income | $864 | $1,023 | $917 | $1,351 |
| % Margin | 13.5% | 16.3% | 14.9% | 21.4% |
| EPS | 3.36 | 4.01 | 3.61 | 5.33 |
| % Growth | -16.2% | 11.1% | -32.3% | – |
| EPS Diluted | 3.33 | 3.99 | 3.59 | 5.33 |
| Weighted Avg Shares Out | 257 | 255 | 254 | 254 |
| Weighted Avg Shares Out Dil | 259 | 256 | 255 | 254 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $520 | $527 | $422 | $258 |
| Depreciation & Amortization | $277 | $236 | $212 | $195 |
| EBITDA | $1,604 | $1,436 | $1,756 | $1,982 |
| % Margin | 25.1% | 22.9% | 28.4% | 31.4% |